First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential

Stem Cells Translational Medicine

Volumn 6, Issue 5, 2017, Pages 1340-1355

  Balbi, Carolina ^a   Piccoli, Martina ^b   Barile, Lucio ^c   Papait, Andrea ^a   Armirotti, Andrea ^d   Principi, Elisa ^a   Reverberi, Daniele ^e   Pascucci, Luisa ^f   Becherini, Pamela ^g   Varesio, Luigi ^g   Mogni, Massimo ^h   Coviello, Domenico ^h   Bandiera, Tiziano ^d   Pozzobon, Michela ^b,i   Cancedda, Ranieri ^a   Bollini, Sveva ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Fondazione Istituto di Ricerca Pediatrica Citta della Speranza   (Italy)

^c DIVISION OF CARDIOLOGY   (Switzerland)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g G GASLINI INSTITUTE   (Italy)

^h GALLIERA HOSPITAL   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; Exosomes; Extracellular vesicles; Fetal stem cells; MiRNA; Paracrine communication; Proliferation; Tissue regeneration

Indexed keywords

MICRORNA; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG;

ADULT; AMNIOTIC FLUID STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; EXOSOME; FETAL STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MATRIGEL PLUG ASSAY; MOUSE; MUSCLE STRENGTH; MYOPATHY; MYOSITIS; NONHUMAN; PARACRINE SIGNALING; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TRANSMISSION ELECTRON MICROSCOPY; AMNION FLUID; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; MUSCLE ATROPHY; PHYSIOLOGY; SKELETAL MUSCLE; STEM CELL;

AMNIOTIC FLUID; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR VESICLES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 85019488997     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.16-0297     Document Type: Article

References (88)

1. Gnecchi M, Zhang Z, Ni A et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204–1219.
2. Mirotsou M, Jayawardena TM, Schmeckpeper J et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011;50:280–289.
3. Bollini S, Gentili C, Tasso R et al. The regenerative role of the fetal and adult stem cell secretome. J Clin Med J Clin Med 2013;2: 302–327.
4. Tetta C, Ghigo E, Silengo L et al. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2012; 44:11–19.
5. Lotvall J, Hill AF, Hochberg F et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014;3:26913.
6. Zhang B, Yeo R, Tan K et al. Focus on extracellular vesicles: Therapeutic potential of stem cell-derived extracellular vesicles. Int J Mol Sci 2016;17:pii: E174.
7. Arslan F, Lai RC, Smeets MB et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013;10:301–312.
8. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4: 214–222.
9. Bian S, Zhang L, Duan L et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 2014;92:387–397.
10. ELLS 2015; 33:2158–2168.
11. Kordelas L, Rebmann V, Ludwig A-K et al. MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014;28:970–973.
12. Bruno S, Grange C, Collino F et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 2012;7:e33115.
13. Tan CY, Lai RC, Wong W et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther 2014;5:76.
14. ELLS 2012;30:1556–1564.
15. ELLS 2015;33: 2748–2761.
16. De Coppi P, BartschG Jr., Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25: 100–106.
17. 1 human amniotic fluid stem cells from second trimester. Methods Mol Biol 2013;1035:191–198.
18. Schiavo AA, Franzin C, Albiero M et al. Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia. Stem Cell Res Ther 2015;6:209.
19. Bollini S, Cheung KK, Riegler J et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 2011;20:1985–1994.
20. Smart N, Bollini S, Dubàe KN et al. De novo cardiomyocytes from within the activated adult heart after injury 2011. Nature 2011;474:640–644.
21. Zani A, Cananzi M, Fascetti-Leon F et al. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 2014;63:300–309.
22. ELLS 2012;30:1675–1684.
23. Mirabella T, Hartinger J, Lorandi C et al. Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap. Stem Cells Dev 2012;21: 2179–2188.
24. Mirabella T, Cilli M, Carlone S et al. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials 2011;32:3689–3699.
25. Mirabella T, Poggi A, Scaranari M et al. Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells implantation. Biomaterials 2011;32:4218–4227.
26. Bekeredjian-Ding I, Foermer S, Kirschning CJ et al. Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes. PLoS One 2012;7:e29806.
27. Zhang H-C, Liu X-B, Huang S et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 2012;21:3289–3297.
28. Ayers L, Nieuwland R, Kohler M et al. Dynamic microvesicle release and clearance within the cardiovascular system: Triggers and mechanisms. Clin Sci (Lond) 2015;129:915– 931.
29. Gray WD, French KM, Ghosh-Choudhary S et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 2015;116:255–263.
30. Bottai D, Cigognini D, Nicora E et al. Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor Neurol Neurosci 2012;30:55–68.
31. Chiavegato A, Bollini S, Pozzobon M et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat 2006. J Mol Cell Cardiol 2007;42:746–759.
32. Barile L, Lionetti V, Cervio E et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 2014;103:530– 541.
33. Caradec J, Kharmate G, Hosseini-Beheshti E et al. Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem 2014;47:1286–1292.
34. Connolly KD, Guschina IA, Yeung V et al. Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipo-genesis. J Extracell Vesicles 2015;24;4:29159.
35. Grisendi G, Finetti E, Manganaro D et al. Detection of microparticles from human red blood cells by multiparametric flow cytometry. Blood Transfus 2015;13:274–280.
36. Judge TA, Wu Z, Zheng XG et al. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999;162:1947–1951.
37. Mareschi K, Castiglia S, Sanavio F et al. Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta. Exp Hematol 2016;44:138–150.
38. de Masson A, Le Buanec H, Bouaziz J-D. Purification and immunophenotypic characterization of human B cells with regulatory functions. Methods Mol Biol 2014;1190:45–52.
39. Heredia JE, Mukundan L, Chen FM et al. Type 2 innate signals stimulate fibro/adipo-genic progenitors to facilitate muscle regeneration. Cell 2013;153:376–388.
40. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000;12:482–491.
41. Fan J, Kou X, Yang Y et al. MircoRNA-regulated proinflammatory cytokines in sarco-penia. Mediators Inflamm 2016;2016: 1438686.
42. Deyhle MR, Gier AM, Evans KC et al. Skeletal muscle inflammation following repeated bouts of lengthening contractions in humans. Front Physiol 2016;6:624.
43. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. AJP Regul Integr Comp Physiol 2010;298:R1173–R1187.
44. Zhang Z, Sun H, Dai H et al. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009;8:2756–2768.
45. Won Kim H, Haider HK, Jiang S et al. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting Caspase-8-associated protein 2. J Biol Chem 2009;284:33161–33168.
46. Keerthikumar S, Chisanga D, Ariyaratne D et al. ExoCarta: A web-based compendium of exosomal cargo. J Mol Biol 2016;428:688–692.
47. Rani S, Ryan AE, Griffin MD et al. Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol Ther 2015;23:812–823.
48. Tetta C, Consiglio AL, Bruno S et al. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; A dream for tendon repair? Muscles Ligaments Tendons J 2012;2:212–221.
49. Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 2013;41:283–287.
50. EL Andaloussi S, M€ager I, Breakefield XO et al. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013;12:347–357.
51. Mohyeldin A, Garzàon-Muvdi T, Qui~nones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010;7:150–161.
52. Salomon C, Ryan J, Sobrevia L et al. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 2013;8:e68451.
53. Yu X, Deng L, Wang D et al. Mechanism of TNF-a autocrine effects in hypoxic cardiomyocytes: Initiated by hypoxia inducible factor 1a, presented by exosomes. J Mol Cell Cardiol 2012;53:848–857.
54. Jun EK, Zhang Q, Yoon BS et al. Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-b/ SMAD2 and PI3K/Akt pathways. Int J Mol Sci 2014;15:605–628.
55. Kang K, Ma R, Cai W et al. Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via Akt signaling pathway following myocardial infarction. Stem Cells Int 2015;2015:659890.
56. ED 2016;5:440–450.
57. Di Trapani M, Bassi G, Fontana E et al. Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age. Stem Cells Dev 2015;24:132– 143.
58. Moorefield EC, McKee EE, Solchaga L et al. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One 2011;6:e26535.
59. Gao F, Chiu SM, Motan DAL et al. Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death Dis 2016;7:e2062.
60. Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: Mode of action and pathways. Ann NY Acad Sci 2015;1351:114–126.
61. Mokarizadeh A, Delirezh N, Morshedi A et al. Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling. Immunol Lett 2012; 147:47–54.
62. Blazquez R, Sanchez-Margallo FM, de la Rosa O et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol 2014;5:556.
63. Zhang B, Yin Y, Lai RC et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev 2014;23:1233–1244.
64. Conforti A, Scarsella M, Starc N et al. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev 2014;23:2591–2599.
65. Budoni M, Fierabracci A, Luciano R et al. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant 2013;22:369–379.
66. Nicole S, Desforges B, Millet G et al. Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. J Cell Biol 2003;161: 571–582.
67. Nakamura Y, Miyaki S, Ishitobi H et al. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett 2015;589:1257–1265.
68. Dutt V, Gupta S, Dabur R et al. Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action. Pharmacol Res 2015;99:86–100.
69. Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 2015;24:199–206.
70. Zhou Y, Zhou G, Tian C et al. Exosome-mediated small RNA delivery for gene therapy. Wiley Interdiscip Rev RNA 2016;7:758–771.
71. Bodempudi V, Hergert P, Smith K et al. miR-210 promotes IPF fibroblast proliferation in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 2014;307:L283–L294.
72. Eulalio A, Mano M, Ferro MD et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012;492:376–381.
73. Zeng L, He X, Wang Y et al. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther 2014;21:37–43.
74. Alaiti MA, Ishikawa M, Masuda H et al. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD341 cells enhances cell-mediated angiogenesis. J Cell Mol Med 2012;16:2413–2421.
75. Cervio E, Barile L, Moccetti T et al. Exosomes for intramyocardial intercellular communication. Stem Cells Int 2015;2015:482171.
76. Wang S, Aurora AB, Johnson BA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261–271.
77. Wang S, Olson EN. AngiomiRs--Key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205–211.
78. Wang B, Yao K, Huuskes BM et al. Mesenchymal stem cells deliver exogenous micro-RNA let7c via exosomes to attenuate renal fibrosis. Mol Ther 2016; 24:1290–1301.
79. Haider KH, Idris NM, Kim HW et al. MicroRNA-21 is a key determinant in IL-11/ Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 2010;88:168–178.
80. Ibrahim AG, Cheng K, Marbàan E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2014;2:606–619.
81. Recchiuti A, Krishnamoorthy S, Fredman G et al. MicroRNAs in resolution of acute inflammation: Identification of novel resolvin D1-miRNA circuits. FASEB J 2011;25: 544–560.
82. Sheedy FJ, Palsson-McDermott E, Hennessy EJ et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010;11:141–147.
83. Asangani IA, Rasheed SAK, Nikolova DA et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intrav-asation and metastasis in colorectal cancer. Oncogene 2008;27:2128–2136.
84. Essandoh K, Li Y, Huo J et al. Mirna-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 2016 46:122–131.
85. Ivan M, Huang X. miR-210: Fine-tuning the hypoxic response. Adv Exp Med Biol 2014; 772:205–227.
86. Lange-Consiglio A, Perrini C, Tasquier R et al. Equine amniotic microvesicles and their anti-inflammatory potential in a tenocyte model in vitro. Stem Cells Dev 2016;25:610– 621.
87. Iglesias DM, El-Kares R, Taranta A et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One 2012;7.
88. Zhang G, Zou X, Miao S et al. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS One 2014;9:e92129.